XML 48 R38.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Segments (Detail)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 01, 2017
USD ($)
Dec. 27, 2015
USD ($)
Jan. 01, 2017
USD ($)
segment
Dec. 27, 2015
USD ($)
Jul. 03, 2016
USD ($)
Segment Reporting Information [Line Items]          
Number of segments | segment     2    
Net sales $ 97,399 $ 103,529 $ 197,766 $ 210,220  
Gross profit 15,898 18,521 33,183 39,659  
Selling and administrative expenses 12,953 14,340 26,336 27,964  
Internal research and development expenses 533 438 884 951  
Restructuring charges 0 2,360 0 2,360  
Reversal of accrued contingent consideration   (1,530)   (1,530)  
Operating income 221 454 1,553 4,952  
Capital expenditures 1,451 1,783 2,570 3,263  
Total assets 223,172 245,998 223,172 245,998 $ 245,998
Operating Segments | Manufacturing and Design Services          
Segment Reporting Information [Line Items]          
Net sales 67,382 67,586 132,384 141,543  
Gross profit 8,357 6,989 15,651 17,285  
Selling and administrative expenses 5,561 6,646 11,537 12,527  
Internal research and development expenses 0 0 0 0  
Restructuring charges   2,360   2,360  
Reversal of accrued contingent consideration   (1,530)   (1,530)  
Operating income 986 (2,524) 472 (183)  
Capital expenditures 464 427 670 1,433  
Total assets 151,020 167,277 151,020 167,277  
Operating Segments | Engineered Components and Products          
Segment Reporting Information [Line Items]          
Net sales 32,350 40,642 69,942 78,731  
Gross profit 7,541 11,532 17,532 22,374  
Selling and administrative expenses 3,545 3,715 7,369 7,312  
Internal research and development expenses 533 438 884 951  
Restructuring charges   0   0  
Reversal of accrued contingent consideration   0   0  
Operating income 3,082 6,957 8,511 13,260  
Capital expenditures 423 228 758 273  
Total assets 63,143 69,627 63,143 69,627  
Unallocated          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Gross profit 0 0 0 0  
Selling and administrative expenses 3,847 3,979 7,430 8,125  
Internal research and development expenses 0 0 0 0  
Restructuring charges   0   0  
Reversal of accrued contingent consideration   0   0  
Operating income (3,847) (3,979) (7,430) (8,125)  
Capital expenditures 564 1,128 1,142 1,557  
Total assets 9,009 9,094 9,009 9,094  
Eliminations          
Segment Reporting Information [Line Items]          
Net sales (2,333) (4,699) (4,560) (10,054)  
Gross profit 0 0 0 0  
Selling and administrative expenses 0 0 0 0  
Internal research and development expenses 0 0 0 0  
Restructuring charges   0   0  
Reversal of accrued contingent consideration   0   0  
Operating income 0 0 0 0  
Capital expenditures 0 0 0 0  
Total assets $ 0 $ 0 $ 0 $ 0